These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7822011)

  • 1. Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent.
    Roeffen W; Geeraedts F; Eling W; Beckers P; Wizel B; Kumar N; Lensen T; Sauerwein R
    Infect Immun; 1995 Feb; 63(2):467-71. PubMed ID: 7822011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing.
    Read D; Lensen AH; Begarnie S; Haley S; Raza A; Carter R
    Parasite Immunol; 1994 Oct; 16(10):511-9. PubMed ID: 7532850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230.
    Healer J; McGuinness D; Carter R; Riley E
    Parasitology; 1999 Nov; 119 ( Pt 5)():425-33. PubMed ID: 10599074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies.
    Quakyi IA; Carter R; Rener J; Kumar N; Good MF; Miller LH
    J Immunol; 1987 Dec; 139(12):4213-7. PubMed ID: 2447164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium falciparum: a comparison of the activity of Pfs230-specific antibodies in an assay of transmission-blocking immunity and specific competition ELISAs.
    Roeffen W; Beckers PJ; Teelen K; Lensen T; Sauerwein RW; Meuwissen JH; Eling W
    Exp Parasitol; 1995 Feb; 80(1):15-26. PubMed ID: 7529717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ELISA units, IgG subclass ratio and avidity determined functional activity of mouse anti-Pfs230 antibodies judged by a standard membrane-feeding assay with Plasmodium falciparum.
    Miura K; Deng B; Wu Y; Zhou L; Pham TP; Diouf A; Wu CK; Lee SM; Plieskatt JL; Morin MJ; Long CA
    Vaccine; 2019 Apr; 37(15):2073-2078. PubMed ID: 30850239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential ability of specific regions of Plasmodium falciparum sexual-stage antigen, Pfs230, to induce malaria transmission-blocking immunity.
    Bustamante PJ; Woodruff DC; Oh J; Keister DB; Muratova O; Williamson KC
    Parasite Immunol; 2000 Aug; 22(8):373-80. PubMed ID: 10972844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of serological tests and bio-assay for malaria transmission blocking capacity in field sera.
    Roeffen W; Beckers PJ; Teelen K; Verhave JP; Eling W; Sauerwein R
    Parassitologia; 1993 Jul; 35 Suppl():95-7. PubMed ID: 7694226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
    Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
    Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-traversal protein for ookinetes and sporozoites (CelTOS) formulated with potent TLR adjuvants induces high-affinity antibodies that inhibit Plasmodium falciparum infection in Anopheles stephensi.
    Pirahmadi S; Zakeri S; A Mehrizi A; D Djadid N; Raz AA; J Sani J; Abbasi R; Ghorbanzadeh Z
    Malar J; 2019 Apr; 18(1):146. PubMed ID: 31014347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human monoclonal antibody blocks malaria transmission and defines a highly conserved neutralizing epitope on gametes.
    Coelho CH; Tang WK; Burkhardt M; Galson JD; Muratova O; Salinas ND; Alves E Silva TL; Reiter K; MacDonald NJ; Nguyen V; Herrera R; Shimp R; Narum DL; Byrne-Steele M; Pan W; Hou X; Brown B; Eisenhower M; Han J; Jenkins BJ; Doritchamou JYA; Smelkinson MG; Vega-Rodríguez J; Trück J; Taylor JJ; Sagara I; Healy SA; Renn JP; Tolia NH; Duffy PE
    Nat Commun; 2021 Mar; 12(1):1750. PubMed ID: 33741942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activity.
    Tachibana M; Wu Y; Iriko H; Muratova O; MacDonald NJ; Sattabongkot J; Takeo S; Otsuki H; Torii M; Tsuboi T
    Clin Vaccine Immunol; 2011 Aug; 18(8):1343-50. PubMed ID: 21715579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of domains within Pfs230 that elicit transmission blocking antibody responses.
    Tachibana M; Miura K; Takashima E; Morita M; Nagaoka H; Zhou L; Long CA; Richter King C; Torii M; Tsuboi T; Ishino T
    Vaccine; 2019 Mar; 37(13):1799-1806. PubMed ID: 30824357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of falciparum malarial forms in naturally infected anophelines in Cameroon using a fluorescent anti-25-kD monoclonal antibody.
    Robert V; Le Goff G; Essong J; Tchuinkam T; Faas B; Verhave JP
    Am J Trop Med Hyg; 1995 Apr; 52(4):366-9. PubMed ID: 7741180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction and enhancement of Plasmodium falciparum transmission by endemic human sera.
    van der Kolk M; de Vlas SJ; Sauerwein RW
    Int J Parasitol; 2006 Sep; 36(10-11):1091-5. PubMed ID: 16790244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Plasmodium falciparum transmission reducing immunity among primary school children in a malaria moderate transmission region in Zimbabwe.
    Paul NH; Vengesai A; Mduluza T; Chipeta J; Midzi N; Bansal GP; Kumar N
    Acta Trop; 2016 Nov; 163():103-8. PubMed ID: 27491342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines.
    Espinosa DA; Vega-Rodriguez J; Flores-Garcia Y; Noe AR; Muñoz C; Coleman R; Bruck T; Haney K; Stevens A; Retallack D; Allen J; Vedvick TS; Fox CB; Reed SG; Howard RF; Salman AM; Janse CJ; Khan SM; Zavala F; Gutierrez GM
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and function of a malaria transmission blocking vaccine targeting Pfs230 and Pfs230-Pfs48/45 proteins.
    Singh K; Burkhardt M; Nakuchima S; Herrera R; Muratova O; Gittis AG; Kelnhofer E; Reiter K; Smelkinson M; Veltri D; Swihart BJ; Shimp R; Nguyen V; Zhang B; MacDonald NJ; Duffy PE; Garboczi DN; Narum DL
    Commun Biol; 2020 Jul; 3(1):395. PubMed ID: 32709983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a continuous and cross-reacting epitope for Plasmodium falciparum transmission-blocking immunity.
    Wizel B; Kumar N
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9533-7. PubMed ID: 1719534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230.
    MacDonald NJ; Nguyen V; Shimp R; Reiter K; Herrera R; Burkhardt M; Muratova O; Kumar K; Aebig J; Rausch K; Lambert L; Dawson N; Sattabongkot J; Ambroggio X; Duffy PE; Wu Y; Narum DL
    J Biol Chem; 2016 Sep; 291(38):19913-22. PubMed ID: 27432885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.